Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 147 JPY -0.6% Market Closed
Market Cap: 32.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Income to Minority Interest

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Income to Minority Interest Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income to Minority Interest CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Income to Minority Interest
ÂĄ236m
CAGR 3-Years
37%
CAGR 5-Years
65%
CAGR 10-Years
42%
Takeda Pharmaceutical Co Ltd
TSE:4502
Income to Minority Interest
-ÂĄ173m
CAGR 3-Years
5%
CAGR 5-Years
-1%
CAGR 10-Years
24%
Daiichi Sankyo Co Ltd
TSE:4568
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Income to Minority Interest
-ÂĄ3.6B
CAGR 3-Years
5%
CAGR 5-Years
1%
CAGR 10-Years
-10%
Chugai Pharmaceutical Co Ltd
TSE:4519
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Income to Minority Interest
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
32.8B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 433.41 JPY
Undervaluation 12%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Income to Minority Interest?
Income to Minority Interest
236m JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Income to Minority Interest amounts to 236m JPY.

What is Daito Pharmaceutical Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
42%

Over the last year, the Income to Minority Interest growth was 223%. The average annual Income to Minority Interest growth rates for Daito Pharmaceutical Co Ltd have been 37% over the past three years , 65% over the past five years , and 42% over the past ten years .

Back to Top